Drugplain

Mulpleta 3 mg/1

Lusutrombopag · TABLET, FILM COATED · Eddingpharm (U. S. ) Inc.

No Recall History
Plain English

Mulpleta is a tablet, film coated containing lusutrombopag at 3 mg/1, taken oral. Manufactured by Eddingpharm (U. S. ) Inc..

Key Facts

Brand Name
Mulpleta
Generic Name
Lusutrombopag
NDC Code (Product)
85320-551
Manufacturer
Eddingpharm (U. S. ) Inc.
Strength
3 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA210923
Marketing Start
11/24/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

death3 reports
drug ineffective3 reports
nausea3 reports
ascites2 reports
diarrhoea2 reports
headache2 reports
hospitalisation2 reports
mesenteric vein thrombosis2 reports
pain2 reports
pancytopenia2 reports

Frequently Asked Questions

What is Mulpleta used for?

Mulpleta contains Lusutrombopag. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is Mulpleta a controlled substance?

Mulpleta is not classified as a controlled substance by the DEA.

What is the generic name for Mulpleta?

The generic name for Mulpleta is Lusutrombopag. There are no other listed brand versions of Lusutrombopag.

What is the NDC code for Mulpleta 3 mg/1?

The NDC (National Drug Code) for Mulpleta 3 mg/1 is 85320-551, listed by Eddingpharm (U. S. ) Inc..

Product NDC

85320-551

Package NDC

85320-551-07

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)